4 ms·
I'm from the country of Ozempic and Wegovy and neither Novo Nordisk nor our media have been portraying these drugs as general purpose anti-addiction drugs. Howe
by dtquad 2y ago
I'm from the country of Ozempic and Wegovy and neither Novo Nordisk nor our media have been portraying these drugs as general purpose anti-addiction drugs. However there have been some international studies that reveal that it might actually be. Can Novo Nordisk extend their patent of their existing drug if they find new applications for the drug?
Some of Silicon Valley's excess productivity over the rest of the world is driven by ADHD medication. Curious what happens when they also start taking GLP-1 medication.
- daveguy 2y agoYes, a patent can be extended with a different use case. Drug repurposing or repositioning is mostly done exactly because of this financial benefit. Unfortunately that does not apply to currently generic drugs, so pharmaceutical companies don't put the resources into repurposing off-patent drugs that could be helpful. https://en.m.wikipedia.org/wiki/Drug_repositioning https://en.m.wikipedia.org/wiki/Drug_repositioning
- BandButcher 2y agosame to your last point as another person mentioned in this thread about people already combining glp's with other drugs, i can see scenarios in which some people abuse glps with adderall or even pain killers to become literal zombies - foregoing breakfast/lunch breaks, working longer hours... imo it could establish an even greater work demand from companies (implicitly) where if you're not on it, you're not "trying" hard enough.